Skip to main content
. Author manuscript; available in PMC: 2017 Aug 11.
Published in final edited form as: J Pharm Pharm Sci. 2014;17(3):371–392. doi: 10.18433/j3n590

Figure 4.

Figure 4

Dextran and glycan-lectin interactions. This simplified scheme shows that if dextran decrease the availability of MR and DC-SIGN for the pathogens, this may influence immune responses. It is known that DC-SIGN ligands prevent binding and entry of pathogens, interfere with trans-infection of T cells by DCs, skew the myeloid cells activation phenotypes and influence immune response.